Literature DB >> 29201447

Lung neuroendocrine tumors: pathological characteristics.

Luisella Righi1, Gaia Gatti1, Marco Volante1, Mauro Papotti2.   

Abstract

Lung neuroendocrine tumors (NETs) are a heterogeneous family of neoplasms comprising four histologic types, namely typical and atypical carcinoid (TC and AC), large-cell neuroendocrine and small cell carcinoma (SCC). Classification criteria include the number of mitoses per 2 mm2, the occurrence and extent of necrosis, cytological and histological features and immunohistochemistry for neuroendocrine markers. The classification system and the diagnostic workflow of lung NETs are apparently easy to apply and well established. However, several unresolved issues still exist in classification and pathological characterization of these tumors, probably because inter-observer diagnostic reproducibility remains disappointing, likely due to inconsistency in recognizing necrosis, mitoses and cytological details, especially in small biopsy or cytological materials. Furthermore, the lack of strong prognostic and grading criteria leads to the incomplete interpretation of some rare intermediate entities that stand in between AC and large cell neuroendocrine carcinoma (LCNEC) categories.

Entities:  

Keywords:  Neuroendocrine; carcinoid; classification; grading; small cell carcinoma (SCC)

Year:  2017        PMID: 29201447      PMCID: PMC5690953          DOI: 10.21037/jtd.2017.01.59

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  21 in total

Review 1.  Grading lung neuroendocrine tumors: Controversies in search of a solution.

Authors:  Giuseppe Pelosi; Linda Pattini; Giovanni Morana; Alessandra Fabbri; Alex Faccinetto; Nicola Fazio; Barbara Valeri; Angelica Sonzogni
Journal:  Histol Histopathol       Date:  2016-09-15       Impact factor: 2.303

2.  Objective quantification of the Ki67 proliferative index in neuroendocrine tumors of the gastroenteropancreatic system: a comparison of digital image analysis with manual methods.

Authors:  Laura H Tang; Mithat Gonen; Cyrus Hedvat; Irvin M Modlin; David S Klimstra
Journal:  Am J Surg Pathol       Date:  2012-12       Impact factor: 6.394

3.  Histologic features of low- and intermediate-grade neuroendocrine carcinoma (typical and atypical carcinoid tumors) of the lung.

Authors:  Koji Tsuta; Maria G Raso; Neda Kalhor; Diane D Liu; Ignacio I Wistuba; Cesar A Moran
Journal:  Lung Cancer       Date:  2010-05-11       Impact factor: 5.705

Review 4.  Classification of lung neuroendocrine tumors: lights and shadows.

Authors:  Marco Volante; Gaia Gatti; Mauro Papotti
Journal:  Endocrine       Date:  2015-03-21       Impact factor: 3.633

5.  Lung parenchymal invasion in pulmonary carcinoid tumor: an important histologic feature suggesting the diagnosis of atypical carcinoid and poor prognosis.

Authors:  Sang Yun Ha; Jae Jun Lee; Junhun Cho; Jiyeon Hyeon; Joungho Han; Hong Kwan Kim
Journal:  Lung Cancer       Date:  2013-02-04       Impact factor: 5.705

Review 6.  Ki-67 antigen in lung neuroendocrine tumors: unraveling a role in clinical practice.

Authors:  Giuseppe Pelosi; Guido Rindi; William D Travis; Mauro Papotti
Journal:  J Thorac Oncol       Date:  2014-03       Impact factor: 15.609

7.  Grading the neuroendocrine tumors of the lung: an evidence-based proposal.

Authors:  G Rindi; C Klersy; F Inzani; G Fellegara; L Ampollini; A Ardizzoni; N Campanini; P Carbognani; T M De Pas; D Galetta; P L Granone; L Righi; M Rusca; L Spaggiari; M Tiseo; G Viale; M Volante; M Papotti; G Pelosi
Journal:  Endocr Relat Cancer       Date:  2013-12-16       Impact factor: 5.678

Review 8.  What clinicians are asking pathologists when dealing with lung neuroendocrine neoplasms?

Authors:  Giuseppe Pelosi; Alessandra Fabbri; Mara Cossa; Angelica Sonzogni; Barbara Valeri; Luisella Righi; Mauro Papotti
Journal:  Semin Diagn Pathol       Date:  2015-10-22       Impact factor: 3.464

9.  Tumorlets, multicentric carcinoids, lymph-nodal metastases, and long-term behavior in bronchial carcinoids.

Authors:  Piero Ferolla; Niccolò Daddi; Moira Urbani; Antonia Semeraro; Rodolfo Ribacchi; Paolo Giovenali; Stefano Ascani; Verena De Angelis; Lucio Crinò; Francesco Puma; Giuliano Daddi
Journal:  J Thorac Oncol       Date:  2009-03       Impact factor: 15.609

10.  Limited role of Ki-67 proliferative index in predicting overall short-term survival in patients with typical and atypical pulmonary carcinoid tumors.

Authors:  Ann E Walts; Delma Ines; Alberto M Marchevsky
Journal:  Mod Pathol       Date:  2012-05-11       Impact factor: 7.842

View more
  7 in total

1.  Comparative study of large cell neuroendocrine carcinoma and small cell lung carcinoma in high-grade neuroendocrine tumors of the lung: a large population-based study.

Authors:  Jian Wang; Ling Ye; Hui Cai; Meiling Jin
Journal:  J Cancer       Date:  2019-07-10       Impact factor: 4.207

2.  Clinicopathological and immunohistochemical study of pulmonary neuroendocrine tumors - A single-institute experience.

Authors:  Uma Jyothi Swaroopa Pasala; Monalisa Hui; Shantveer G Uppin; N Narendra Kumar; K Bhaskar; G K Paramjyothi
Journal:  Lung India       Date:  2021 Mar-Apr

3.  Hierarchical identification of a transcriptional panel for the histological diagnosis of lung neuroendocrine tumors.

Authors:  Juxuan Zhang; Jiaxing Deng; Xiao Feng; Yilong Tan; Xin Li; Yixin Liu; Mengyue Li; Haitao Qi; Lefan Tang; Qingwei Meng; Haidan Yan; Lishuang Qi
Journal:  Front Genet       Date:  2022-08-29       Impact factor: 4.772

4.  Combined Large Cell Neuroendocrine Carcinomas of the Lung: Integrative Molecular Analysis Identifies Subtypes with Potential Therapeutic Implications.

Authors:  Michele Simbolo; Giovanni Centonze; Luca Giudice; Federica Grillo; Patrick Maisonneuve; Anastasios Gkountakos; Chiara Ciaparrone; Laura Cattaneo; Giovanna Sabella; Rosalba Giugno; Paola Bossi; Paola Spaggiari; Alessandro Del Gobbo; Stefano Ferrero; Luca Mastracci; Alessandra Fabbri; Martina Filugelli; Giovanna Garzone; Natalie Prinzi; Sara Pusceddu; Adele Testi; Valentina Monti; Luigi Rolli; Alessandro Mangogna; Luisa Bercich; Mauro Roberto Benvenuti; Emilio Bria; Sara Pilotto; Alfredo Berruti; Ugo Pastorino; Carlo Capella; Maurizio Infante; Michele Milella; Aldo Scarpa; Massimo Milione
Journal:  Cancers (Basel)       Date:  2022-09-24       Impact factor: 6.575

5.  Angioside: The role of Angiogenesis and Hypoxia in Lung Neuroendocrine Tumours According to Primary Tumour Location in Left or Right Parenchyma.

Authors:  Anna La Salvia; Raffaella Carletti; Monica Verrico; Tiziana Feola; Giulia Puliani; Massimiliano Bassi; Franz Sesti; Angelina Pernazza; Rossella Mazzilli; Giuseppe Lamberti; Alessandra Siciliani; Massimiliano Mancini; Chiara Manai; Federico Venuta; Mohsen Ibrahim; Silverio Tomao; Giulia D'Amati; Cira Di Gioia; Elisa Giannetta; Federico Cappuzzo; Antongiulio Faggiano
Journal:  J Clin Med       Date:  2022-10-09       Impact factor: 4.964

6.  Outcomes of Patients with Clinical Stage I-IIIA Large-Cell Neuroendocrine Lung Cancer Treated with Resection.

Authors:  Anna Lowczak; Agnieszka Kolasinska-Cwikla; Jarosław B Ćwikła; Karolina Osowiecka; Jakub Palucki; Robert Rzepko; Lidka Glinka; Anna Doboszyńska
Journal:  J Clin Med       Date:  2020-05-07       Impact factor: 4.241

7.  Incidence, treatment, and survival analysis in esophageal neuroendocrine carcinoma population.

Authors:  Zhenhua Li; Jiali Hu; Pifeng Chen; Zhi Zeng
Journal:  Transl Cancer Res       Date:  2020-07       Impact factor: 1.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.